Back to Search
MICHAEL SCHIFF, MD
MD
Surgery Physician
NPI: 1578127163Individual
Specialties, Licenses & Credentials
Oral and Maxillofacial Surgery (Dentist)
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
339108(NY)
Surgery PhysicianPrimary
Surgery
Code: 208600000X
339108(NY)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase.
PMID 24972708·Ann Rheum Dis·2014
3-trial
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
PMID 19235592·Cancer Invest·2009
3-trial
Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease.
PMID 19361758·Biol Blood Marrow Transplant·2009
3-trial
NCAM and polysialyltransferase profiles match dopaminergic marker gene expression but polysialic acid is dispensable for development of the midbrain dopamine system.
PMID 19619134·J Neurochem·2009
4-observational
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
PMID 18701556·Ann Rheum Dis·2009
2-rct
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
PMID 19678751·Curr Med Res Opin·2009
3-trial
Identifying previous sports injury among high school athletes.
PMID 19171912·Clin Pediatr (Phila)·2009
8-other
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial.
PMID 19074911·Ann Rheum Dis·2009
3-trial
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data.
PMID 19074177·Ann Rheum Dis·2009
3-trial
Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.
PMID 19242930·Hum Mutat·2009
8-other
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.
PMID 19015207·Ann Rheum Dis·2009
3-trial
Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
PMID 19228659·J Rheumatol·2009
2-rct
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
PMID 18490431·Ann Rheum Dis·2009
4-observational
Linking the response properties of cells in auditory cortex with network architecture: cotuning versus lateral inhibition.
PMID 18784296·J Neurosci·2008
7-preclinical
The Heidelberg Peri-anaesthetic Questionnaire--development of a new refined psychometric questionnaire.
PMID 18717664·Anaesthesia·2008
4-observational
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
PMID 18576334·Arthritis Rheum·2008
4-observational
Pregnancy outcomes following hospitalisation for a fall in Washington State from 1987 to 2004.
PMID 18947341·BJOG·2008
8-other
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
PMID 19022808·Ann Rheum Dis·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 650 W BALTIMORE ST STE 1401
BALTIMORE, MD 21201 - Phone
- (410) 706-6195
Quick Facts
- NPI
- 1578127163
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile